1. Symptoms after breast cancer treatment: are they influenced by patient characteristics?

   • Jean Yoon
   • Jennifer L. Malin
   • Katherine L. Kahn

   Review 10 May 2007 Pages: 153 - 165

   

2. Breast cancer risk in women with radial scars in benign breast biopsies

   • Jena C. Berg
   • Daniel W. Visscher
   • Lynn C. Hartmann

   Review 22 May 2007 Pages: 167 - 174

   

3. Selective ET_AR antagonist atrasentan inhibits hypoxia-induced breast cancer cell invasion

   • M. Smollich
   • M. Götte
   • P. Wülfing

   Preclinical Study 28 April 2007 Pages: 175 - 182

   

4. HER2 expression and efficacy of preoperative paclitaxel/FAC chemotherapy in breast cancer

   • Fabrice Andre
   • Chafika Mazouni
   • Lajos Pusztai

   Preclinical Study 28 April 2007 Pages: 183 - 190

   

5. Predicting features of breast cancer with gene expression patterns

   • Xuesong Lu
   • Xin Lu
   • Andrea L. Richardson

   Preclinical Study 22 May 2007 Pages: 191 - 201

   

6. Role of manganese superoxide dismutase on growth and invasive properties of human estrogen-independent breast cancer cells

   • Zilal Kattan
   • Vanessa Minig
   • Philippe Becuwe

   Preclinical Study 02 May 2007 Pages: 203 - 215

   

7. Relation of demographic factors, menstrual history, reproduction and medication use to sex hormone levels in postmenopausal women

   • Anne McTiernan
   • LieLing Wu
   • For the WHI Investigators

   Clinical Trial 22 May 2007 Pages: 217 - 231

8. Gene expression patterns in formalin-fixed, paraffin-embedded core biopsies predict docetaxel chemosensitivity in breast cancer patients

   • Jenny C. Chang
   • Andreas Makris
   • Steven Shak

   Clinical Trial 28 April 2007 Pages: 233 - 240

   

9. Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer

   • Keun Seok Lee
   • Hyun Cheol Chung
   • Jungsil Ro

   Clinical Trial 03 May 2007 Pages: 241 - 250

   

10. Bone marrow cytokeratin 19 mRNA level is an independent predictor of relapse-free survival in operable breast cancer patients

    • Ragne K. Farmen
    • Oddmund Nordgård
    • Reino Heikkilä

    Clinical Trial 10 May 2007 Pages: 251 - 258

    

11. Phase III randomized multicenter study on the effects of adjuvant CMF in patients with node-negative, rapidly proliferating breast cancer: twelve-year results and retrospective subgroup analysis

    • Dino Amadori
    • Oriana Nanni
    • Rosella Silvestrini

    Clinical Trial 26 May 2007 Pages: 259 - 264

    

12. Decision making in adjuvant trials in breast cancer: the NCIC CTG MA.17 trial as an example

    • Joseph Pater
    • Dongsheng Tu
    • Paul E. Goss

    Clinical Trial 03 May 2007 Pages: 265 - 269

13. Fiberoptic ductoscopy combined with cytology testing in the patients of spontaneous nipple discharge

    • Guang-Yu Liu
    • Jing-Song Lu
    • Zhi-Min Shao

    Clinical Trial 02 May 2007 Pages: 271 - 277

    

14. Effects of a combined aerobic and resistance exercise program in breast cancer survivors: a randomized controlled trial

    • Helen M. Milne
    • Karen E. Wallman
    • Kerry S. Courneya

    Clinical Study 26 May 2007 Pages: 279 - 288

    

15. Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers

    • T. Byrski
    • J. Gronwald
    • the Polish Hereditary Breast Cancer Consortium

    Epidemiology 10 May 2007 Pages: 289 - 296

16. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis

    • Elise M. Pelletier
    • Boyung Shim
    • Mayur M. Amonkar

    Epidemiology 19 June 2007 Pages: 297 - 305